Dr Catherine Hanna

  • NES Clinical Lecturer - Clinical Oncology (Clinical Trials Research)

Publications

List by: Type | Date

Jump to: 2019 | 2017 | 2016 | 2015 | 2013
Number of items: 7.

2019

Hanna, C.R. , Lynskey, D.M., Wadsley, J., Appleyard, S.E., Anwar, S., Miles, E., Gower, J., Hall, E., Coles, C.E. and Hanna, G.G. (2019) Radiotherapy trial set-up in the UK: identifying inefficiencies and potential solutions. Clinical Oncology, (doi: 10.1016/j.clon.2019.10.004) (PMID:31685377) (In Press)

2017

Lorimer, C.F., Hanna, C. , Saran, F., Chalmers, A. and Brock, J. (2017) Challenges to treating older glioblastoma patients: the influence of clinical and tumour characteristics on survival outcomes. Clinical Oncology, 29(11), pp. 739-747. (doi: 10.1016/j.clon.2017.05.010) (PMID:28807361)

2016

Conteduca, V. et al. (2016) Association between early PSA increase and clinical outcome in patients treated with enzalutamide for metastatic castration resistant prostate cancer. Molecular Diagnosis and Therapy, 20(3), pp. 255-263. (doi: 10.1007/s40291-016-0196-1) (PMID:27020582)

Conteduca, V. et al. (2016) Persistent neutrophil to lymphocyte ratio >3 during treatment with enzalutamide and clinical outcome in patients with castration-resistant prostate cancer. PLoS ONE, 11(7), e0158952. (doi: 10.1371/journal.pone.0158952) (PMID:27434372) (PMCID:PMC4951050)

2015

Hanna, C. and Jones, R. J. (2015) Emerging treatments for recurrent prostate cancer. Future Oncology, 11(21), pp. 2873-2880. (doi: 10.2217/fon.15.228) (PMID:26436556)

2013

Johnston, M., Guo, L., Back, M., Guminski, A., Lee, A., Hanna, C. , Veivers, D., Wignall, A. and Eade, T. (2013) Intensity-modulated radiotherapy using simultaneous-integrated boost for definitive treatment of locally advanced mucosal head and neck cancer: Outcomes from a single-institution series. Journal of Medical Imaging and Radiation Oncology, 57(3), pp. 356-363. (doi: 10.1111/1754-9485.12033) (PMID:23721147)

Hanna, C. , Dhaun, N., Squires, M. and Watson, S. (2013) Haemolytic anaemia complicating the concurrent use of allopurinol & azathioprine after kidney transplantation. International Journal of Basic and Clinical Pharmacology, 2(3), pp. 330-332. (doi: 10.5455/2319-2003.ijbcp20130619)

This list was generated on Tue Feb 25 10:38:27 2020 GMT.
Jump to: Articles
Number of items: 7.

Articles

Hanna, C.R. , Lynskey, D.M., Wadsley, J., Appleyard, S.E., Anwar, S., Miles, E., Gower, J., Hall, E., Coles, C.E. and Hanna, G.G. (2019) Radiotherapy trial set-up in the UK: identifying inefficiencies and potential solutions. Clinical Oncology, (doi: 10.1016/j.clon.2019.10.004) (PMID:31685377) (In Press)

Lorimer, C.F., Hanna, C. , Saran, F., Chalmers, A. and Brock, J. (2017) Challenges to treating older glioblastoma patients: the influence of clinical and tumour characteristics on survival outcomes. Clinical Oncology, 29(11), pp. 739-747. (doi: 10.1016/j.clon.2017.05.010) (PMID:28807361)

Conteduca, V. et al. (2016) Association between early PSA increase and clinical outcome in patients treated with enzalutamide for metastatic castration resistant prostate cancer. Molecular Diagnosis and Therapy, 20(3), pp. 255-263. (doi: 10.1007/s40291-016-0196-1) (PMID:27020582)

Conteduca, V. et al. (2016) Persistent neutrophil to lymphocyte ratio >3 during treatment with enzalutamide and clinical outcome in patients with castration-resistant prostate cancer. PLoS ONE, 11(7), e0158952. (doi: 10.1371/journal.pone.0158952) (PMID:27434372) (PMCID:PMC4951050)

Hanna, C. and Jones, R. J. (2015) Emerging treatments for recurrent prostate cancer. Future Oncology, 11(21), pp. 2873-2880. (doi: 10.2217/fon.15.228) (PMID:26436556)

Johnston, M., Guo, L., Back, M., Guminski, A., Lee, A., Hanna, C. , Veivers, D., Wignall, A. and Eade, T. (2013) Intensity-modulated radiotherapy using simultaneous-integrated boost for definitive treatment of locally advanced mucosal head and neck cancer: Outcomes from a single-institution series. Journal of Medical Imaging and Radiation Oncology, 57(3), pp. 356-363. (doi: 10.1111/1754-9485.12033) (PMID:23721147)

Hanna, C. , Dhaun, N., Squires, M. and Watson, S. (2013) Haemolytic anaemia complicating the concurrent use of allopurinol & azathioprine after kidney transplantation. International Journal of Basic and Clinical Pharmacology, 2(3), pp. 330-332. (doi: 10.5455/2319-2003.ijbcp20130619)

This list was generated on Tue Feb 25 10:38:27 2020 GMT.

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • CRUK CTU Glasgow - Clinical Trial Fellowship
    Cancer Research UK
    2018 - 2018
     

Research datasets

Jump to: 2019
Number of items: 1.

2019

Ross, K., Keith, N. , Aitchison, I., Allbutt, E., Banks, E., Basra, S., Bilsland, A., Charalambous, A., Chapal, C., Drummond, M., Dunipace, S., Erridge, A., Fremin-Besombes, M., Glasspool, R., Hamilton, V., Hanna, C. , Herfurth, L., Humpleby, M., Hush, G., Ivanova, Y., Jones, R. , Kaleta-Pyrek, A., Kalt, L., Kantor, M., Karolak, G., Keith, A., Klink, S., Laing, B., Lister, A., Mallon, E., Mccann, E., McLaughlin, R., Merchant, Z., Mozel, A., Mrozek, O., Painter, C., Paul, J. , Paxton, J., Perry, M. , Prendergast, E., Proudfoot, B., Raina, T., Roberts, F., Safrany, S., Scott, J., Sleight, R., Smith, C., Strain, E., Stricevic, M., Svanera, S., Tobias, E. , Vansteenhouse, H., Williams, N. and Zhang, H. (2019) A collaborative approach to exploring the future of Cancer treatment and care in relation to Precision Medicine: A design perspective. [Data Collection]

This list was generated on Tue Feb 25 00:10:32 2020 GMT.